Clinical Trials Directory

Trials / Unknown

UnknownNCT02494154

Effects of Treatment With High Flow Nasal Cannulas on Respiratory Pattern and Work of Breathing Among Patients.

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
16 (estimated)
Sponsor
Laval University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study evaluates the work of breathing among patients under various conditions of treatment with high flow nasal cannulas. Sixteen spontaneously breathing patients with respiratory failure (hypercapnic or hypoxemic) will be included. The design of this study is a cross over of four treatment periods with different flow settings.

Detailed description

High flow oxygen therapy (HFOT) is a promising technique increasingly used in the management of acute respiratory failure. In hospitalised hypoxemic patients, recent clinical evidence showed that HFOT can reduce endotracheal intubation and reduce mortality. Physiologically, the HFOT causes a decrease in respiratory rate and minute-ventilation and may be associated with a decrease in PaCO2. It is possible that these effects are associated with decreased work of breathing, which could explain some of the benefits in terms of comfort and efficiency. The objective of this research is to evaluate the impact of a wash-out of anatomical dead space by high flow nasal cannulas on respiratory parameters and on the work of breathing. The investigators will evaluate the baseline status with conventional oxygen therapy methods (low flows), and then compare it with three different levels of high flow oxygen therapy in a randomised order. The primary endpoint will be the work of breathing.

Conditions

Interventions

TypeNameDescription
DEVICEAirvo 2; Ficher and Paykel HealthCareHigh flow nasal cannulas
DEVICEOxygen delivery via conventional nasal maskLow flow of oxygen delivered through conventional nasal prongs

Timeline

Start date
2015-05-01
Primary completion
2015-10-01
First posted
2015-07-10
Last updated
2015-07-10

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT02494154. Inclusion in this directory is not an endorsement.